Additional priority legislation being supported and opposed include:

• 340B Drug Pricing Program: Support for 340B program reforms through House Bill 2371 (see also PhRMA-backed reforms proposed in HB5421 / SB3878; and click here for an infographic and podcast discussion of the competing 340B proposals)

• Menopause-Related Care: Promotion of menopause education through Senate Bill 3325, which integrates into current implicit bias continuing education requirements and is an initiative of the Lt. Governor (see also HB5284 and SB3688, which contain additional menopause-related policy proposals that may be combined into a larger menopause equity package this session)

• Prior Authorization: Amending House Bill 4709 to preserve all 2021 prior authorization protections won by IAFP and healthcare coalition allies; (HB 4709 is an initiative of the National Coalition of Insurance Legislators (NCOIL), which also utilizes American Medical Association (AMA) model law provisions finalized at the national level in 2025)